Subjects: RITUXIMAB; ANTINEOPLASTIC agents; CANCER chemotherapyGENENTECH Inc. GENENTECH Inc. GENENTECH Inc. DNA; F. Hoffmann-La Roche Ltd.
Record details
Subjects: RITUXIMAB; CLINICAL trials; DRUG developmentF. Hoffmann-La Roche Ltd.
Subjects: *SALES; RITUXIMAB; ANTINEOPLASTIC agentsGENENTECH Inc. GENENTECH Inc. GENENTECH Inc. DNA; F. Hoffmann-La Roche Ltd.
Subjects: CLINICAL trials; RITUXIMAB; MULTIPLE sclerosis treatmentUNITED StatesBIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIIB; GENENTECH Inc. GENENTECH Inc. GENENTECH Inc. DNA
Subjects: RITUXIMAB; LYMPHOMA treatmentINTAS Pharmaceuticals Ltd.
Subjects: RITUXIMABUNITED States. Food & Drug Administration
Subjects: CLINICAL trials; RITUXIMAB; MONOCLONAL antibodiesEUROPEAN Union
Subjects: RITUXIMAB; CLINICAL trials; ANTINEOPLASTIC agentsF. Hoffmann-La Roche Ltd.
Subjects: *SALES; *PHARMACEUTICAL industry; RITUXIMABEUROPE
Subjects: RITUXIMAB; EMERGING marketsINDIA